These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 36593968)
21. Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax. Waclawiczek A; Leppä AM; Renders S; Stumpf K; Reyneri C; Betz B; Janssen M; Shahswar R; Donato E; Karpova D; Thiel V; Unglaub JM; Grabowski S; Gryzik S; Vierbaum L; Schlenk RF; Röllig C; Hundemer M; Pabst C; Heuser M; Raffel S; Müller-Tidow C; Sauer T; Trumpp A Cancer Discov; 2023 Jun; 13(6):1408-1427. PubMed ID: 36892565 [TBL] [Abstract][Full Text] [Related]
22. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia. Liu B; Ma H; Liu Q; Xiao Y; Pan S; Zhou H; Jia L J Exp Clin Cancer Res; 2019 May; 38(1):200. PubMed ID: 31097000 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells. Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018 [TBL] [Abstract][Full Text] [Related]
24. MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Jiang X; Huang H; Li Z; He C; Li Y; Chen P; Gurbuxani S; Arnovitz S; Hong GM; Price C; Ren H; Kunjamma RB; Neilly MB; Salat J; Wunderlich M; Slany RK; Zhang Y; Larson RA; Le Beau MM; Mulloy JC; Rowley JD; Chen J Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19397-402. PubMed ID: 23132946 [TBL] [Abstract][Full Text] [Related]
25. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia. Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078 [TBL] [Abstract][Full Text] [Related]
26. Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane. Liang B; Jiang D; Pan L; Xiong F; Feng S; Wu S; Ye H; Yu Z; Shi C; Gao S Acta Biomater; 2022 Jun; 145():246-259. PubMed ID: 35405327 [TBL] [Abstract][Full Text] [Related]
27. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. Zhu XN; Wei YS; Yang Q; Liu HR; Zhi Z; Zhu D; Xia L; Hong DL; Yu Y; Chen GQ J Hematol Oncol; 2023 Feb; 16(1):9. PubMed ID: 36774506 [TBL] [Abstract][Full Text] [Related]
28. The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia. Zhang X; Zeng J; Zhou M; Li B; Zhang Y; Huang T; Wang L; Jia J; Chen C Mol Cancer; 2012 Aug; 11():56. PubMed ID: 22900969 [TBL] [Abstract][Full Text] [Related]
29. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. Chen P; Price C; Li Z; Li Y; Cao D; Wiley A; He C; Gurbuxani S; Kunjamma RB; Huang H; Jiang X; Arnovitz S; Xu M; Hong GM; Elkahloun AG; Neilly MB; Wunderlich M; Larson RA; Le Beau MM; Mulloy JC; Liu PP; Rowley JD; Chen J Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11511-6. PubMed ID: 23798388 [TBL] [Abstract][Full Text] [Related]
30. A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells. Gao XN; Lin J; Ning QY; Gao L; Yao YS; Zhou JH; Li YH; Wang LL; Yu L PLoS One; 2013; 8(2):e55481. PubMed ID: 23390536 [TBL] [Abstract][Full Text] [Related]
31. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia. Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development. Schneider E; Staffas A; Röhner L; Krowiorz K; Heuser M; Döhner K; Bullinger L; Döhner H; Fogelstrand L; Rouhi A; Kuchenbauer F; Palmqvist L Exp Hematol; 2016 Dec; 44(12):1166-1171. PubMed ID: 27619068 [TBL] [Abstract][Full Text] [Related]
33. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets. Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404 [TBL] [Abstract][Full Text] [Related]
34. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis. Li A; Yang Y; Gao C; Lu J; Jeong HW; Liu BH; Tang P; Yao X; Neuberg D; Huang G; Tenen DG; Chai L J Clin Invest; 2013 Oct; 123(10):4195-207. PubMed ID: 24051379 [TBL] [Abstract][Full Text] [Related]
35. Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway. Zhao C; Du F; Zhao Y; Wang S; Qi L Stem Cell Res Ther; 2019 Dec; 10(1):384. PubMed ID: 31842997 [TBL] [Abstract][Full Text] [Related]
36. miR-99 regulates normal and malignant hematopoietic stem cell self-renewal. Khalaj M; Woolthuis CM; Hu W; Durham BH; Chu SH; Qamar S; Armstrong SA; Park CY J Exp Med; 2017 Aug; 214(8):2453-2470. PubMed ID: 28733386 [TBL] [Abstract][Full Text] [Related]
37. Single-cell dissection reveals promotive role of ENO1 in leukemia stem cell self-renewal and chemoresistance in acute myeloid leukemia. Tian Y; Guo J; Mao L; Chen Z; Zhang X; Li Y; Zhang Y; Zha X; Luo OJ Stem Cell Res Ther; 2024 Oct; 15(1):347. PubMed ID: 39380054 [TBL] [Abstract][Full Text] [Related]
38. HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML. Li Z; Wang F; Tian X; Long J; Ling B; Zhang W; Xu J; Liang A J Exp Clin Cancer Res; 2021 Jun; 40(1):210. PubMed ID: 34167558 [TBL] [Abstract][Full Text] [Related]
39. Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis. Huang J; Jin S; Guo R; Wu W; Yang C; Qin Y; Chen Q; He X; Qu J; Yang Z RNA; 2024 Mar; 30(4):435-447. PubMed ID: 38296629 [TBL] [Abstract][Full Text] [Related]
40. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML). Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]